Schedule 13D ownership disclosure

SOL-GEL TECHNOLOGIES LTD

Ordinary Shares, par value NIS 1.0 per share · CUSIP: M8694L137

Event date: 2025-05-29

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Moshe ArkinReported CIK 0001321178

    Shares: 1,950,113 · Class: 65.31%

  • M. Arkin Dermatology Ltd.

    Shares: 1,806,856 · Class: 60.52%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001178913-25-002176
Form type
SCHEDULE 13D/A
Filer
Arkin Moshe
CIK
CIK 1321178
Filed
Jun 12, 2025
Reporting period
May 29, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub